The research achievement of the research group that arsenic trioxide restores the anti-cancer function of p53 structural mutant has been interpreted in a long article in Cancer Cell
The research results of the research group on arsenic trioxide restoring the anti-cancer function of p53 structural mutant were published online in Cancer Cell on December 26, 2020, which has caused a great response in both academic and industrial circles at home and abroad
Basic research and clinical translation of p53 targeting small molecules – [sponsored by Hua’an Biotechnology] BioArt and One Work Face to Face (Oncology, Issue 2)
https://mp.weixin.qq.com/s/nK3rQSm4bNM4u9sAN5UqAw